Diabetes, Prediabetes Linked to Older Brain Age
Patients with diabetes and prediabetes have older brain ages than their chronological age compared with normoglycemic patients.
ASHP’s Outlook for the Pharmacy Profession in 2025
Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.
Q&A: Building a Better Future for Community Pharmacy
Jennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.
Racial Disparities Significant in Children Receiving Nutrition, Lifestyle Counseling
In a post hoc secondary analysis of the BP-CATCH trial, researchers explored the best ways of screening children with high blood pressure and managing their care.
Obesity in Adolescents: Prevalence, Health Effects, and Treatment Options
Adolescent obesity rates have risen in recent years, and a number of treatment options can be taken to help reduce the risk of a variety of associated medical problems.
Micronutrient Deficiencies Common Among Patients With Type 2 Diabetes
A recent systematic review and meta-analysis found that almost half of all patients with type 2 diabetes were deficient in multiple micronutrients.
Q&A: Raising Awareness About Maternity Care Deserts Among Community Pharmacists
Natalie DiPietro Mager, PharmD, PhD, discusses the role of community pharmacy in maternal health.
Q&A: The Rise of AI in Alleviating Health Care Workforce Challenges
Scott Nelson, PharmD, MS, FAMIA, ACHIP, discussed the increasingly crucial role artificial intelligence has played in streamlining pharmacy services.
Gestational Age Associated with Pain Among Very Preterm Infants
Researchers analyzed liveborn infant data from January 2020 to June 2024 to determine prevalence, cause, and treatment strategies for pain among preterm infants.
FDA Approves Ozempic for Improving CKD Outcomes in Adults with T2D
Ozempic is now the most broadly indicated glucagon-like peptide-1 receptor agonist across the pharmaceutical drug market.
Cebranopadol Shows Lower Abuse Potential Compared to Existing Pain Therapies
A supratherapeutic dose of 1000 ug cebranopadol was significantly less likeable compared to 40 mg oxycodone when crushed and taken intranasally.
Secukinumab Demonstrates Real-World Efficacy in Treating Psoriatic Arthritis
Researchers conducted a literature review of patients’ clinical experiences with using secukinumab to treat psoriatic arthritis.
Adderall Shortage Led to More Alternative Stimulant Prescriptions for US Children
Researchers analyzed overall prescription stimulant dispensing trends among US children from 2017 to 2023.
Pharmacists Can Play Important Role in Contraceptive Services
A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.
Q&A: How Health Systems Must Navigate Pharmacy, Medical Benefits
Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, sat down with Drug Topics to discuss challenges within the business behind health-system pharmacies.
Dapagliflozin Comparable with Empagliflozin for Long-Term Kidney Outcomes in T2D
Among a population of patients with type 2 diabetes, researchers assessed the similarities and differences between SGLT2 inhibitors.
How Pharmacists Can Integrate Maternity Care Services Into Routine Workflows
Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, provides best tips and practices for providing maternity care.
Q&A: Pharmacists Can Help Raise Awareness About CGMs
Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Q&A: Pharmacists’ Play Key Role in Alleviating Primary Care Gap
Jonathan Watanabe, PharmD, MS, PhD, BCGP, joined Drug Topics to discuss how pharmacists can facilitate improved patient outcomes through collaborative care.
NCPA Joins Class Action Suit Against GoodRx, Industry-Leading PBMs
Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.
NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy
The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.
Pharmacists Critical for Helping Patients in Maternity Care Deserts
A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.
Pediatric Obesity Treatment Reduced Mortality, Long-Term Morbidity in Young Adults
To highlight the effectiveness of pediatric obesity treatment, researchers measured its impact on morbidity and mortality in young adulthood.
Nonopioid Therapy Shown to Significantly Reduce Pain Intensity in Phase 3 Trial
Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.
Moderna Receives $590 Million From HHS to Develop Bird Flu Vaccine
The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.
Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System
Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.
Sociodemographic, Clinical Factors Associated with Semaglutide Initiation in Adults with Obesity
For adults with obesity but no diabetes diagnosis, researchers searched for the key factors leading to semaglutide initiation.
FDA Approves Spravato as Monotherapy for Major Depressive Disorder
The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.
Q&A: Identifying, Addressing Gaps in Primary Care
Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed a section of the ASHP 2025 Pharmacy Forecast that he co-authored titled “Addressing the Gap in Primary Care.”
